2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theAcute Care Syndromic Testing Market?

The increasing occurrence of infectious diseases is anticipated to propel the acute care syndromic testing market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread between individuals, animals, or the environment. The rising number of infectious diseases is influenced by population growth, urbanization, global travel, antimicrobial resistance, and climate change, intensifying the need for effective disease prevention and treatment. Acute care syndromic testing facilitates rapid identification of pathogens and co-infections using multiplex molecular diagnostics, enabling targeted treatment approaches. For instance, in February 2024, the Health Security Agency, a UK-based government organization, reported that in week 4 of 2024, the influenza positivity rate increased to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also climbed to 9.8 per 100,000 people, compared to 7.5 per 100,000 the prior week. Additionally, influenza-related hospitalizations rose to 7.63 per 100,000, up from 5.12 per 100,000 the previous week. Therefore, the increasing prevalence of infectious diseases is fueling the growth of the acute care syndromic testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21078&type=smp

#How Does the ProjectedAcute Care Syndromic Testing Market Growth Compare Over the Forecast Period?

The acute care syndromic testing market has expanded rapidly in recent years. It is forecasted to rise from $4.08 billion in 2024 to $4.62 billion in 2025, with a CAGR of 13.2%. The past growth was driven by heightened awareness of antimicrobial resistance, increased government funding for infectious diseases, greater investment in healthcare infrastructure, a growing emphasis on syndromic testing, the expansion of telemedicine, and the rising prevalence of infectious diseases.

The acute care syndromic testing market size is expected to grow rapidly in the coming years. By 2029, it is estimated to reach $7.50 billion at a compound annual growth rate (CAGR) of 12.9%. This growth is driven by the increasing prevalence of infectious diseases, rising demand for faster diagnostic solutions, the expansion of healthcare services, greater use of multiplex syndromic panels, and an aging global population. Key trends forecasted for this period include a shift towards point-of-care testing, integration of cloud-based platforms, adoption of multiplex panels, the development of AI-powered diagnostic tools, and increased automation in syndromic testing.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21078

Which Cutting-Edge Market Trends Are Expected to Drive theAcute Care Syndromic Testing Market’s Growth?

In the acute care syndromic testing market, companies are advancing multiplex real-time PCR technology to enhance diagnostic accuracy and enable rapid pathogen detection. For instance, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in April 2023. This system, capable of detecting over 20 pathogens from a single sample, provides rapid results with minimal labor, significantly improving diagnostic efficiency and patient outcomes.

What Are the Leading Market Players Impacting theAcute Care Syndromic Testing Market’s Growth Trend?

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/acute-care-syndromic-testing-global-market-report

How Are the Key Segments of the Acute Care Syndromic Testing Market Driving Opportunities and Innovations?

The acute care syndromic testing market covered in this report is segmented –

1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types

2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types

3) By Target: Bacteria, Viruses, Fungi, Parasites

4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users

Subsegments:

1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases

2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases

3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases

4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases

5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21078&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theAcute Care Syndromic Testing Market?# Market Expansion?

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Acute Care Syndromic Testing Market 2025, By The Business Research Company:

Anthrax Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anthrax-vaccine-global-market-report

Dendritic Cell Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report

Cell and Gene Therapy Global Market Report 2025

https://thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: